{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "9038081",
  "DateCompleted": {
    "Year": "1997",
    "Month": "03",
    "Day": "25"
  },
  "DateRevised": {
    "Year": "2016",
    "Month": "10",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1079-7440",
      "JournalIssue": {
        "Volume": "50",
        "Issue": "6",
        "PubDate": {
          "Year": "1996",
          "Season": "Nov-Dec"
        }
      },
      "Title": "PDA journal of pharmaceutical science and technology",
      "ISOAbbreviation": "PDA J Pharm Sci Technol"
    },
    "ArticleTitle": "Enhancing effect of non-ionic surfactant on the inactivation of lipopolysaccharide by steam-heat treatment I.",
    "Pagination": {
      "StartPage": "360",
      "EndPage": "365",
      "MedlinePgn": "360-5"
    },
    "Abstract": {
      "AbstractText": [
        "Polyoxyethylene (20) sorbitan mono-fatty acid esters strongly enhanced the inactivation of lipopolysaccharide (LPS) by steam-heat treatment at 121 degrees C, as assayed by using the Limulus amebocyte lysate (LAL) and the pyrogen test. In an aqueous solution containing 0.1% surfactant, the decrease of LPS (1 microgram/ml) from E. coli 055:B5 at 121 degrees C followed first-order kinetics. Based on the LAL assay, 0.1% surfactant was essential to achieve 3-log cycle reduction of LPS with concomitant loss of pyrogenicity by steam-heat treatment for 20 min at 121 degrees C. Steam-heat treatment for 20 min at 121 degrees C in the absence of surfactant was insufficient to achieve depyrogenation. Polyoxyethylene (9) lauryl ether and decaglycerin mono-laurate similarly enhanced depyrogenation by steam-heat treatment. The effects of all the surfactants were concentration-dependent for all of the six kinds of LPS examined."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Pharmaceutical Research Center, Shiseido Company, Yokohama, Japan."
          }
        ],
        "LastName": "Bamba",
        "ForeName": "T",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Matsui",
        "ForeName": "R",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Watabe",
        "ForeName": "K",
        "Initials": "K"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "PDA J Pharm Sci Technol",
    "NlmUniqueID": "9439538",
    "ISSNLinking": "1079-7440"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Lipopolysaccharides"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Surface-Active Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Feasibility Studies"
    },
    {
      "QualifierName": [
        "etiology",
        "prevention & control"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Hot Temperature"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Infusions, Parenteral"
    },
    {
      "QualifierName": [
        "chemistry"
      ],
      "DescriptorName": "Lipopolysaccharides"
    },
    {
      "QualifierName": [
        "chemistry"
      ],
      "DescriptorName": "Surface-Active Agents"
    }
  ]
}